In:
Clinical Infectious Diseases, Oxford University Press (OUP), ( 2023-11-14)
Abstract:
We evaluated Ibalizumab (IBA)-containing standardized optimized salvage regimen (with or without a four-week foscarnet induction) in individuals harboring multidrug-resistant-HIV-2. Nine were included; two achieved virological suppression after foscarnet induction with a sustained suppression at Week 24 after IBA initiation, and an additional individual at Week 24 after Ibalizumab initiation.
Type of Medium:
Online Resource
ISSN:
1058-4838
,
1537-6591
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2023
detail.hit.zdb_id:
2002229-3
Permalink